跳至主要内容
临床试验/JPRN-UMIN000011244
JPRN-UMIN000011244已完成未知

A prospective, open label, randomized, controlled trial of tocilizumab versus cyclophosphamide in patients with microscopic polyangiitis - Tocilizumab versus cyclophosphamide in microscopic polyangiitis

Saitama Medical Center, Saitama Medical University Department of Rheumatology and Clinical Immunology0 个研究点目标入组 40 人开始时间: 2013年9月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) patients who are prohibited to use tocilizumab by the JCR guideline for proper tocilizumab use 2) patients who are thought to be inappropriate for tocilizumab by their attending doctor

研究者

发起方
Saitama Medical Center, Saitama Medical University Department of Rheumatology and Clinical Immunology

相似试验

A prospective, open label, randomized, controlled... | 临床试验